Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes

Published:2017-02-28 Issue:10 Volume:58 Page:2379-2386
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Trubiano Jason A.¹²,Dickinson Michael³,Thursky Karin A.¹²⁴,Spelman Timothy²,Seymour John F.²³,Slavin Monica A.¹²⁴,Worth Leon J.¹²

Affiliation:

1. Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Australia;

2. Department of Medicine, University of Melbourne, Melbourne, Australia;

3. Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia;

4. Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute, Melbourne, Australia

Funder

unrestricted Merk, Sharp & Dohme (MSD)

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1295141

Reference27 articles.

1. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

2. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

3. Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

4. Epidemiology and risk factors for infections in myelodysplastic syndromes

5. Infections in myelodysplastic syndromes

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes;Seminars in Hematology;2024-08

2. No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group;Frontiers in Oncology;2024-06-13

3. Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome;Clinical Lymphoma Myeloma and Leukemia;2024-05

4. Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine—A Retrospective Analysis;Cancers;2024-03-29

5. One Case of Drug-Resistant Invasive Fungal Infection after Myelodysplastic Syndrome Chemotherapy;Clinical Laboratory;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3